FIELD: medicine.
SUBSTANCE: invention relates to biotechnology and represents antibody, which is bound with human hepatocyte growth factor activator (HGFA). Also described is method of treating disease associated with impaired regulation of HGF/c-met-mediated signal that applies antibody.
EFFECT: invention can be efficiently used in treatment of diseases, associated with regulation of HGF/c-met-mediated signal.
18 cl, 23 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HUMANISED ANTI c-met ANTAGONISTS | 2005 |
|
RU2398777C2 |
| METHOD OF TUMOUR TREATMENT IN SUBJECT | 2006 |
|
RU2404193C2 |
| ANTI c-Met RECEPTOR PROTEIN ANTIBODIES | 2011 |
|
RU2608644C2 |
| COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER | 2011 |
|
RU2595389C2 |
| ANTI-HEPSIN ANTIBODIES AND METHODS OF APPLICATION THEREOF | 2010 |
|
RU2559533C2 |
| COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMOUR | 2011 |
|
RU2636461C2 |
| ANTI-c-Met ANTIBODY | 2009 |
|
RU2560257C2 |
| ANTI-TAT226 ANTIBODIES AND IMMUNOCONJUGATES | 2007 |
|
RU2448980C2 |
| ANTI-CD40-ANTIBODIES AND METHODS OF APPLICATION | 2012 |
|
RU2609647C2 |
| ANTI-BV8 ANTIBODIES AND USING THEM | 2010 |
|
RU2559542C2 |
